REF Impact Statements and Gene Panels
- Research in the Centre for Endocrinology under the leadership of Professor Louise Metherell has greatly improved diagnosis and understanding of Adrenal Insufficiency, characterising recessive gene mutations and developing a novel and cost-effective genetic screening panel, which is helping patients to receive swift, appropriate, effective treatment and genetic counselling for this life-threatening disorder.
- Professor Helen Storr has led on the development of a genetic panel for diagnosing short stature. Short stature affects ~2% of UK children and is a common reason for referral (~50%) to paediatric endocrinology clinics. Approximately half of short children referred to specialty clinics have a treatable condition but most (80-90%) do not currently obtain a diagnosis. Queen Mary’s centre is recognised as an international referral centre for genetic testing of patients with undiagnosed growth failure. The short stature gene panel has reduced the diagnostic time and more than 60% of patients referred have obtained a specific genetic diagnosis which has led to targeted treatment and management plans.

- Clinical Trials and Outcomes
- Websites for Referring Patients with Rare Endocrine Disorders for Genetic Diagnoses & Helpful Patient Information
- REF Impact Statements and Gene Panels
- Pioneering Research and Treatments in Paediatric and Adult Endocrinology
- Informed and influenced Guidelines for Management of Endocrine and Cardiovascular Patients
- Award-winning MSc in Clinical Endocrinology and Diabetes
- Editorial Boards and Recent Journal Covers